511 related articles for article (PubMed ID: 27129421)
1. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
2. Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents.
Cadieux CL; Wang H; Zhang Y; Koenig JA; Shih TM; McDonough J; Koh J; Cerasoli D
Chem Biol Interact; 2016 Nov; 259(Pt B):133-141. PubMed ID: 27062893
[TBL] [Abstract][Full Text] [Related]
3. Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents.
Koplovitz I; Harris LW; Anderson DR; Lennox WJ; Stewart JR
Fundam Appl Toxicol; 1992 Jan; 18(1):102-6. PubMed ID: 1601200
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig.
Wilhelm CM; Snider TH; Babin MC; Platoff GE; Jett DA; Yeung DT
Neurotoxicology; 2018 Sep; 68():142-148. PubMed ID: 30056178
[TBL] [Abstract][Full Text] [Related]
5. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
[TBL] [Abstract][Full Text] [Related]
6. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.
Worek F; Reiter G; Eyer P; Szinicz L
Arch Toxicol; 2002 Sep; 76(9):523-9. PubMed ID: 12242610
[TBL] [Abstract][Full Text] [Related]
7. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
Maxwell DM; Koplovitz I; Worek F; Sweeney RE
Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
9. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
Nichols RH; Chambers JE
Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
[TBL] [Abstract][Full Text] [Related]
11. Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
Shih TM; Skovira JW; McDonough JH
Arch Toxicol; 2009 Dec; 83(12):1083-9. PubMed ID: 19763542
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
13. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
Esposito EX; Stouch TR; Wymore T; Madura JD
Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
[TBL] [Abstract][Full Text] [Related]
15. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates.
Chambers JE; Chambers HW; Meek EC; Pringle RB
Chem Biol Interact; 2013 Mar; 203(1):135-8. PubMed ID: 23123249
[TBL] [Abstract][Full Text] [Related]
16. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
17. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
[TBL] [Abstract][Full Text] [Related]
18. The tertiary oxime monoisonitrosoacetone penetrates the brain, reactivates inhibited acetylcholinesterase, and reduces mortality and morbidity following lethal sarin intoxication in guinea pigs.
Shih TM; Oyler BL; Capacio BR; Koplovitz I
Toxicol Appl Pharmacol; 2021 Mar; 415():115443. PubMed ID: 33548273
[TBL] [Abstract][Full Text] [Related]
19. The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation.
Maček Hrvat N; Zorbaz T; Šinko G; Kovarik Z
Toxicol Lett; 2018 Sep; 293():222-228. PubMed ID: 29180286
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX.
Chambers JE; Chambers HW; Funck KE; Meek EC; Pringle RB; Ross MK
Chem Biol Interact; 2016 Nov; 259(Pt B):154-159. PubMed ID: 27387540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
